Neil Woodford’s Patient Capital investment trust, which has lost 25 per cent since launch just less than three years ago, remains popular with Hargreaves Lansdown clients.
Mr Woodford launched the trust in 2015, with the aim of investing in a combination of quoted and unquoted companies in areas such as tech and biotech.
The £613m trust is among the ten most popular on the Hargreaves Lansdown platform.
The remainder of the top ten list is made up of funds run by some of the best known names in the City.
The £6.9bn Scottish Mortgage investment trust run by James Anderson and Tom Slater, the £1.2bn Finsbury Growth and Income trust run by Nick Train, and the £1.5bn City of London investment trust, run by Job Curtis, are also among the ten most bought with Hargreaves Lansdown clients.
Laith Khalaf, senior analyst at Hargreaves Lansdown said: “[Scottish Mortgage] invests in companies with the potential to dominate their industry - wherever they are located. It’s no surprise to see companies like Amazon and Tesla among its largest investments, along with Chinese e-commerce and technology companies such as Baidu and Tencent. They have performed well in recent years.”
He noted the shares of the trust presently trade at a discount to net assets, which is rare for this fund..
Popular trusts with a more global focus that are among the top ten include RIT, a £3.3bn multi-asset fund that invests in other funds, and is chaired by Lord Rothschild. The £2.1bn Witan investment trust, which invests in global equities by investing in other funds, also makes the top ten.
The rest of the list is comprised of the Fidelity China Special Situations trust, the Edinburgh Investment Trust and the F&C investment trust.